Clinical trial
Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly…
NCT00274833 · David Peereboom, Other · Completed
Key facts
| NCT number | NCT00274833 |
|---|---|
| Title | Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
| Official title | A Phase II Trial of Erlotinib With Temozolomide and Concurrent Radiation Therapy Post-Operatively in Patients With Newly Diagnosed Glioblastoma Multiforme |
| Lead sponsor | David Peereboom, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | CNS Tumor, Adult |
| Intervention type | Drug, Radiation |
| Interventions | erlotinib hydrochloride, temozolomide, radiation therapy |
| Enrollment | 27 |
| Start date | Oct 1, 2005 |
| Primary completion | Oct 1, 2007 |
| Completion | Sep 1, 2012 |
| First posted | Jan 11, 2006 |
| Last update posted | Dec 6, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: